Trexquant Investment’s ALX Oncology ALXO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-20,990
| Closed | -$234K | – | 1494 |
|
2024
Q1 | $234K | Buy |
+20,990
| New | +$234K | ﹤0.01% | 1340 |
|
2023
Q4 | – | Sell |
-14,269
| Closed | -$68.5K | – | 1392 |
|
2023
Q3 | $68.5K | Sell |
14,269
-36,162
| -72% | -$174K | ﹤0.01% | 1407 |
|
2023
Q2 | $379K | Buy |
50,431
+7,162
| +17% | +$53.8K | 0.01% | 1109 |
|
2023
Q1 | $196K | Buy |
43,269
+26,520
| +158% | +$120K | 0.01% | 1324 |
|
2022
Q4 | $189K | Buy |
+16,749
| New | +$189K | 0.01% | 1256 |
|
2022
Q3 | – | Sell |
-22,211
| Closed | -$180K | – | 1329 |
|
2022
Q2 | $180K | Buy |
+22,211
| New | +$180K | 0.01% | 1377 |
|
2022
Q1 | – | Sell |
-28,678
| Closed | -$616K | – | 1314 |
|
2021
Q4 | $616K | Buy |
28,678
+25,280
| +744% | +$543K | 0.04% | 556 |
|
2021
Q3 | $251K | Sell |
3,398
-843
| -20% | -$62.3K | 0.02% | 842 |
|
2021
Q2 | $232K | Buy |
+4,241
| New | +$232K | 0.02% | 833 |
|